News Source: The Independent
| about 1 month ago
The biotechnology minnow Phytopharm received a huge share price boost yesterday after announcing that early trials of its potential Parkinson's disease treatment had produced impressive results. Phytopharm's shares closed up 339.6 per cent at 26.95p...
News Source: Androscoggin News
| about 1 month ago
Macaque monkeys that received gene therapy for symptoms of Parkinson's disease saw a significant improvement in their motor function without the side effects associated with current standard therapy, researchers say. Simultaneous insertion of three...
News Source: The Courier-Mail
| about 1 month ago
Parkinson's disease that has been tested on lab monkeys is showing good early results in a small-scale trial on humans, French researchers say. The therapy entails taking three genes that produce dopamine, a vital neurochemical that is depleted in...
News Source: Xtra News
| about 1 month ago
Long-term tests on monkeys using Oxford BioMedica's gene therapy ProSavin suggest it can treat Parkinson's disease without causing the jerky, involuntary movements associated with current drugs, researchers said on Wednesday. Parkinson's is caused by...